Beranda › Hipertensi Arteri Pulmonal › California
Uji klinis Hipertensi Arteri Pulmonal di California
12 studi untuk Hipertensi Arteri Pulmonal mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- UC Davis - Medial Center ( Site 1064), Sacramento
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07218029A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA012, Los Angeles
- USA008, Santa Barbara
- USA005, Torrance
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Cedars Sinai, Beverly Hills
- Jeffrey S. Sager, MD Medical Corporation, Santa Barbara
- Lundquist at Harbor UCLA, Torrance
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07365332Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Valley Advanced Lung Diseases Institute, Fresno
- Department of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
- UC Davis Health Medical Center, Sacramento
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- UC Irvine Medical Center, Orange
- Stanford Medical Center, Stanford
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06649110A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
- Stanford University, Stanford
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT06872112Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 1606), Los Angeles
- Stanford University School of Medicine ( Site 1603), Palo Alto
- UCSF Benioff Children's Hospital San Francisco ( Site 1611), San Francisco
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT05587712Pulmonary Hypertension Association Registry
- UC Davis Health, Sacramento
- UCSF Medical Center, San Francisco
- UCSF Benioff Children's Hospital, San Francisco
- dan 2 lainnya
Menerima pesertaStudi observasional
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of California-Los Angeles, Los Angeles
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Stanford University Medical Center, Palo Alto
- University California San Francisco, San Francisco
Menerima pesertaStudi observasional
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 13 Mar 2025 · NCT02249923Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.